Clinical Trial Update: Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating the metformin component of a fixed-dose combination tablet with canagliflozin versus metformin co-administered with cana…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• metformin (metformin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Bioequivalence | Phase 1 | Status: COMPLETED